Clinical trial Recruiting at 1 site Interventional Ages 18 to 80

Autologous Fat Grafting for Chronic Tendinopathy

Official title: Autologous Fat Grafting for the Treatment of Chronic Tendinopathy

Run by Weill Medical College of Cornell University · NCT07748793 · Data updated 2026-11-12

This study tests whether a person’s own processed fat injected into a painful tendon can reduce pain and improve function in adults with chronic tendinopathy who have not improved with standard treatments.

More Tendinopathy trials

Quick facts

Study typeInterventional
Ages18 Years to 80 Years
SexAll
Enrollment40 (estimated)
SponsorWeill Medical College of Cornell University
Academic / other
Locations1 site (New York, New York)
StatusRecruiting
StartedOctober 31, 2026
Main results expectedJanuary 2028
Study endsJuly 2028
Registry record updatedSeptember 25, 2026
Trial IDNCT07748793 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18–80 with chronic tendinopathy (pain >3 months) confirmed on ultrasound and who have failed at least 6 weeks of conservative treatment.

Probably not a fit

Patients with full-thickness tendon tears, prior target-site surgery, recent injections, pregnancy, active infection, significant adjacent joint arthritis, or unsafe medical conditions may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This single-group study examines a one-time injection of autologous adipose-derived tissue (ASSET) into a painful tendon to see if it reduces pain, enhances tendon function, and is safe. Participants are adults 18 to 80 with long-standing tendinopathy confirmed by ultrasound and persistent symptoms despite conventional therapies. Outcomes include changes in pain, function, and ultrasound findings compared to baseline. There is no separate control group; each participant serves as their own comparator. The trial is led by Weill Cornell Medicine with collaboration from The Plastic Surgery Foundation, at the Weill Department of Rehabilitation Medicine in New York.

Why it matters

Potential benefit: If successful, participants may experience reduced tendon pain and improved function after the ASSET injection.

How similar studies have gone: Other studies using autologous adipose-derived therapies for musculoskeletal conditions have shown potential benefits, but results vary and this approach remains investigational in tendinopathy.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria

1. Age 18-80 years.
2. Tendinopathy at any tendon location (e.g., rotator cuff/supraspinatus, lateral epicondyle, gluteal/hip, Achilles, patellar).
3. Confirmed tendon pathology: pain at the tendon site for \> 3 months AND pathology confirmed on ultrasound.
4. Failure of conservative treatment (e.g., activity modification, physical therapy, NSAIDs, corticosteroid injection, and/or PRP) for at least 6 weeks.
5. Able to provide informed consent and complete questionnaires in English.

Exclusion Criteria

1. Full-thickness tendon tear.
2. Prior surgery at the target tendon site.
3. Injection or other intervention at the target tendon site within the prior 6 months.
4. Pregnancy or breastfeeding.
5. Active local or systemic infection, bleeding diathesis or anticoagulation precluding the procedure, or other condition that in the investigator's judgment makes participation unsafe.
6. Moderate-to-high-grade arthritis in the adjacent joint.

Where it's running

  • Department of Rehabilitation Medicine WCMC
    New York, New York, United States
    Recruiting

Study contacts

  • Principal investigator: Jaspal Singh, MD — Department of Rehabilitation Medicine | Weill Cornell Medicine
  • Study coordinator: Terrence Green
  • Email: teg7008@med.cornell.edu
  • Phone: (212) 746-9224

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.